N.C. Tassopoulos

541 total citations
20 papers, 425 citations indexed

About

N.C. Tassopoulos is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, N.C. Tassopoulos has authored 20 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hepatology, 14 papers in Epidemiology and 3 papers in Infectious Diseases. Recurrent topics in N.C. Tassopoulos's work include Hepatitis C virus research (16 papers), Hepatitis B Virus Studies (14 papers) and Liver Disease Diagnosis and Treatment (6 papers). N.C. Tassopoulos is often cited by papers focused on Hepatitis C virus research (16 papers), Hepatitis B Virus Studies (14 papers) and Liver Disease Diagnosis and Treatment (6 papers). N.C. Tassopoulos collaborates with scholars based in Greece, Norway and United States. N.C. Tassopoulos's co-authors include Angelos Hatzakis, Vana Sypsa, D. Tsantoulas, M. Raptopoulou, G. Kitis, Dimitrios Paraskevis, Eleni Papachristou, K. Krawczyński, Karen A. McCaustland and Albert W. Tam and has published in prestigious journals such as New England Journal of Medicine, Journal of Hepatology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

N.C. Tassopoulos

20 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
N.C. Tassopoulos Greece	11	373	341	86	36	21	20	425
M. A. Madwar Egypt	7	273 0.7×	225 0.7×	33 0.4×	25 0.7×	27 1.3×	11	346
Maki Kojima Japan	5	430 1.2×	345 1.0×	46 0.5×	76 2.1×	13 0.6×	8	460
Kurt W. Roth Germany	7	371 1.0×	327 1.0×	39 0.5×	83 2.3×	21 1.0×	8	404
Ali Farhoudi Belgium	11	514 1.4×	400 1.2×	120 1.4×	24 0.7×	64 3.0×	16	595
S.F.A. Patruno Italy	9	209 0.6×	192 0.6×	72 0.8×	41 1.1×	15 0.7×	23	308
Marta Bes Spain	12	436 1.2×	261 0.8×	178 2.1×	14 0.4×	40 1.9×	31	536
Abeer Elkady Japan	15	359 1.0×	347 1.0×	42 0.5×	11 0.3×	20 1.0×	18	479
Frauke Metzler Germany	6	461 1.2×	474 1.4×	31 0.4×	21 0.6×	21 1.0×	6	510
Yoshitaka Etoh Japan	11	368 1.0×	308 0.9×	55 0.6×	30 0.8×	27 1.3×	19	422
Kris Krawczynski United States	8	265 0.7×	143 0.4×	134 1.6×	10 0.3×	20 1.0×	11	321

Countries citing papers authored by N.C. Tassopoulos

Since Specialization

Citations

This map shows the geographic impact of N.C. Tassopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N.C. Tassopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N.C. Tassopoulos more than expected).

Fields of papers citing papers by N.C. Tassopoulos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N.C. Tassopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N.C. Tassopoulos. The network helps show where N.C. Tassopoulos may publish in the future.

Co-authorship network of co-authors of N.C. Tassopoulos

This figure shows the co-authorship network connecting the top 25 collaborators of N.C. Tassopoulos. A scholar is included among the top collaborators of N.C. Tassopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N.C. Tassopoulos. N.C. Tassopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sypsa, Vana, Maria Chini, George Papatheodoridis, et al.. (2006). Analytical and clinical sensitivity of the Procleix Ultrio HIV‐1/HCV/HBV assay in samples with a low viral load. Vox Sanguinis. 92(1). 8–14. 18 indexed citations

Gatselis, Nikolaos, S. P. Georgiadou, George Κ. Koukoulis, et al.. (2006). Clinical significance of organ‐ and non‐organ‐specific autoantibodies on the response to anti‐viral treatment of patients with chronic hepatitis C. Alimentary Pharmacology & Therapeutics. 24(11-12). 1563–1573. 32 indexed citations

Hadziyannis, S., N.C. Tassopoulos, Ting‐Yu Chang, et al.. (2006). P.102 Long-term adefovir dipivoxil treatment induces regression of liver fibrosis in patients with HBeAg-negative chronic hepatitis B: results after 5 years of therapy. Journal of Clinical Virology. 36. S92–S92. 46 indexed citations

Sypsa, Vana, N.C. Tassopoulos, John Boletis, et al.. (2005). Molecular epidemiology of hepatitis C virus (HCV) in Greece: temporal trends in HCV genotype‐specific incidence and molecular characterization of genotype 4 isolates. Journal of Viral Hepatitis. 13(1). 19–27. 71 indexed citations

Hadziyannis, Stephanos J., N.C. Tassopoulos, E. Jenny Heathcote, et al.. (2005). Long-term (3-year) Therapy with Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen Negative Chronic Hepatitis B. New England Journal of Medicine. 352(26). 9 indexed citations

Sypsa, Vana, Giota Touloumi, George Papatheodoridis, et al.. (2004). 270 Future trends of HCV-related cirrhosis and hepatocellular carcinoma under the currently available treatments. Journal of Hepatology. 40. 84–84. 1 indexed citations

Tassopoulos, N.C., I. Ketikoglou, D. Tsantoulas, et al.. (2003). A randomized trial to assess the efficacy of interferon‐alpha daily in combination with ribavirin in the treatment of naïve patients with chronic hepatitis C. Journal of Viral Hepatitis. 10(5). 383–389. 5 indexed citations

Tassopoulos, N.C., D. Tsantoulas, M. Raptopoulou, et al.. (2003). A randomized trial to assess the efficacy of interferon alpha in combination with ribavirin in the treatment of interferon alpha nonresponders with chronic hepatitis C: superior efficacy of high daily dosage of interferon alpha in genotype 1. Journal of Viral Hepatitis. 10(3). 189–196. 9 indexed citations

Paraskevis, Dimitrios, N.C. Tassopoulos, M. Raptopoulou, et al.. (2002). Development and assessment of a novel real-time PCR assay for quantitation of HBV DNA. Journal of Virological Methods. 103(2). 201–212. 68 indexed citations

10.

Tassopoulos, N.C., et al.. (2001). Histological improvement in chronic hepatitis C patients treated with combination of Alpha-Interferon and ribavirin who failed previously to respond to interferon monotherapy. Annals of Gastroenterology. 14(4). 1 indexed citations

11.

Paraskevis, Dimitrios, et al.. (2001). Development of a novel real-time PCR assay for the quantitation of HBV DNA. Journal of Hepatology. 34. 129–129. 1 indexed citations

12.

Papatheodoridis, George, Johanna K. Delladetsima, Antigoni Katsoulidou, et al.. (1997). Significance of IgM anti-HCVcore level in chronic hepatitis C. Journal of Hepatology. 27(1). 36–41. 13 indexed citations

13.

Tassopoulos, N.C., et al.. (1997). Recombinant interferon‐α therapy for acute hepatitis B: a randomized, double‐blind, placebo‐controlled trial. Journal of Viral Hepatitis. 4(6). 387–394. 18 indexed citations

14.

Tassopoulos, N.C., et al.. (1997). Differential diagnosis of acute HBsAg positive hepatitis using IgM anti-HBc by a rapid, fully automated microparticle enzyme immunoassay. Journal of Hepatology. 26(1). 14–19. 17 indexed citations

15.

Tassopoulos, N.C., et al.. (1996). Comparative efficacy of a high or low dose of interferon alpha 2b in chronic hepatitis C: a randomized controlled trial.. PubMed. 91(9). 1734–8. 19 indexed citations

16.

Tassopoulos, N.C., et al.. (1993). Quantitative detection of hepatitis B virus DNA in sera from patients with acute hepatitis B. Digestive Diseases and Sciences. 38(12). 2156–2162. 2 indexed citations

17.

Purdy, Michael A., Karen A. McCaustland, K. Krawczyński, et al.. (1992). Expression of a hepatitis E virus (HEV)-trpE fusion protein containing epitopes recognized by antibodies in sera from human cases and experimentally infected primates. Archives of Virology. 123(3-4). 335–349. 57 indexed citations

18.

Papanicolaou, Michael, et al.. (1990). HLA‐associated non‐responsiveness to Hepatitis B vaccine. Tissue Antigens. 35(2). 60–63. 33 indexed citations

19.

Dimopoulou, Ioanna, et al.. (1988). [A new case of Hodgkin's disease in a patient with human immunodeficiency virus seropositivity].. PubMed. 17(38). 2037–8. 1 indexed citations

20.

Roumeliotou‐Karayannis, A., et al.. (1987). Prevalence of HBV HDV and LAV/HTLV-III infections among Greek drug addicts.. PubMed. 234. 403–4. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact